HemoSonics, LLC is a U.S. medical-device company that develops point-of-care blood coagulation and hemostasis testing technology. Its Quantra Hemostasis System is used by hospitals and surgical teams to assess clot formation and guide blood-product management during procedures.
Subscribe to see HemoSonics, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
HemoSonics, LLC is a medical devices company headquartered in Charlottesville, United States. It has raised at least $23.9M across the 4 funding rounds on record. Its most recent funding round raised $15M in January 2017. Xcout tracks 8 named people at HemoSonics, LLC, including Raymond L Szafranski Jr (Chief Financial Officer).
As of 20 November 2026. Source: Xcout Intel.
2 more named people on record for HemoSonics, LLC, with roles, board committees and tenure — see the full roster →
At least $23.9M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $15M | — | |
| SEC Form D filing | $4M | — | |
| SEC Form D filing | $3.7M | — | |
| Seed | $1.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of HemoSonics, LLC's closest competitors — see the full list of competitors and alternatives →
Coagulation Sciences LLC develops personalized medicine products and analytical instruments, specifically the Multiple Coagulation Test System, for hospitals and blood banks. The company's technology is designed to diagnose coagulation disorders, evaluate multiple treatment therapies, reduce unnecessary blood transfusions, and improve patient safety.
Stasys Medical Corp. is a medical device company co-founded in 2013, focusing on haemostasis monitoring solutions. Headquartered in Seattle, Washington, the company develops specialized diagnostic healthcare equipment.
HemoCue AB develops and manufactures point-of-care medical diagnostic systems and testing equipment. The company serves healthcare providers in clinical settings, hospitals, blood banks, and public health sectors by offering portable devices for hematology, diabetes management, and infection detection.
Accriva Diagnostics is a San Diego, California-based diagnostic company specializing in hemostasis, acute care diagnostics, and platelet reactivity testing. Formed by the 2013 merger of International Technidyne Corporation and Accumetrics, the company is now a part of Instrumentation Laboratory (Werfen).
Magnolia Medical Technologies develops medical devices, such as the Steripath platform, designed to reduce blood culture contamination and improve diagnostic accuracy for sepsis testing. The company serves hospitals, healthcare systems, and clinical professionals by providing solutions that support infection prevention and diagnostic stewardship.
BlueDop Medical develops cuffless lower limb vascular assessment systems utilizing Doppler waveform analysis and proprietary algorithms. The portable technology is designed for healthcare professionals—including podiatrists, community nurses, vascular surgeons, and emergency medicine clinicians—to provide fast, accurate, and pain-free vascular health screening without the need for patient rest periods.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about HemoSonics, LLC? Suggest a correction · Work at HemoSonics, LLC? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.